Rifamycin O (CAS No. 14487-05-9)

1. What Is Rifamycin O? Rifamycin O is a semi-synthetic antibiotic belonging to the rifamycin group, with a molecular formula of C₄₈H₆₈N₄O₁...

R&D

Advancing Pharmaceutical Excellence Since 2020

Kaifeng Darui Pharmaceutical Co., Ltd., a ​high-tech enterprise​ established in 2020, specializes in the R&D, production, and distribution of premium ​veterinary APIs, ​food additives, and ​pharmaceutical intermediates. With a registered capital of ¥27 million and rapid growth (2024 output: ¥60M+, tax contribution: ¥2M+), we combine scientific rigor with sustainable practices to redefine industry standards.


Core R&D Capabilities

1. ​State-of-the-Art Infrastructure

  • GMP-Certified Facilities: Designed per China’s Veterinary Drug Production Quality Management norms, featuring:
    • D-grade cleanrooms​ with independent air purification systems
    • 700㎡ API production area (synthesis + refining/packaging)
    • Advanced equipment: precision distillation units, 150t/d wastewater treatment, RCO exhaust systems

2. ​Cutting-Edge Analytical Capabilities

Our labs leverage world-class instrumentation for quality assurance:

  • Chromatography: Shimadzu HPLC, Yichun GC, Fourier-transform IR
  • Precision Tools: UV-Vis spectrophotometers, electronic analytical balances, stability test chambers

3. ​Expert-Led Innovation

  • 20+ specialized researchers​ (20% of workforce), including 2 professors and 4 senior engineers
  • University collaborations: Henan Academy of Chemical Sciences, Pingdingshan University
  • Active patent portfolio: 12 utility patents (e.g., bromonitro alcohol yield enhancement systems) + 4 pending

Strategic Industry Leadership

Key Achievements

  • 2023 High-Tech Enterprise Certification​ (Henan Province)
  • 2022 Innovative SME Award
  • 18 GMP Certificates​ for veterinary APIs (issued Nov 2024)

Market-Focused Development

  • Pet Healthcare Solutions: Developing antiparasitics (e.g., albendazole derivatives) and antiviral APIs
  • Global Expansion: Cost-competitive API exports with rising international recognition
  • 3-Year Roadmap: Targeting ¥100M output by 2025, doubling R&D investment to ¥20M

Sustainable Growth Philosophy

Guided by our motto “Quality for Survival, Talent for Foundation; Science for Growth, Management for Efficiency,” we prioritize:

  • Green Chemistry: Closed-loop systems for solvent recovery and low-waste synthesis
  • Talent Cultivation: 70%+ staff with tertiary education in specialized training programs
  • Community Impact: 2023 “Charitable Enterprise” honoree for social responsibility initiatives

Why Partner with Darui Pharma?​

  • End-to-End Expertise: From molecular design to scaled GMP production
  • IP-Protected Solutions: Customizable intermediates like brominated alkanes and chlorobenzamide derivatives
  • Regulatory Mastery: Full compliance with veterinary medicine and food additive regulations

Contact Us​ to explore API development, technology transfers, or custom synthesis projects.


My Instagram